Paul Ian

Paul Ian Cross is a multifaceted individual with expertise in science, writing, education, and entrepreneurship. He holds degrees in Applied Biology (BSc), Clinical Research (MSc), and a PhD that investigated the benefit-risk assessment of medicines from the patient's perspective. With over twenty years of experience in clinical research, Paul has contributed to over a hundred clinical studies, including first-in-human clinical trials in gene and cell therapy and COVID-19 vaccine research. He provides consultancy services to organizations involved in clinical research, offering expertise in areas such as study design, ICH Good Clinical Practice oversight, project management, science communication, and writing. Paul is passionate about making STEM subjects accessible and interesting for both children and adults. His educational drive is evident through the compelling STEM content he shares across his social media platforms. In addition to his scientific pursuits, Paul is an award-nominated author with a diverse range of work, including STEM-inspired books for children and young adults, science fiction, non-fiction, cosy mysteries, and MM romance. He is also dedicated to teaching English as a second language with a focus on healthcare professionals and students. Paul's unique combination of skills allows him to bridge the worlds of science, literature, and language education. With a strong foundation in biology and interests in health, medicine, nature, technology, environmental sustainability, climate change, and space exploration; Paul's scientific curiosity also extends to artificial intelligence and the possibility of alien life. These interests often find their way into his science fiction narratives. Paul aims not only to inform but also to inspire; making science approachable and fun for a wider audience. Medical News Today Editorial Guidelines.

100%

The Daily's Verdict

This author is known for its high journalistic standards. The author strives to maintain neutrality and transparency in its reporting, and avoids conflicts of interest. The author has a reputation for accuracy and rarely gets contradicted on major discrepancies in its reporting.

Bias

100%

Examples:

No current examples available.

Conflicts of Interest

100%

Examples:

No current examples available.

Contradictions

85%

Examples:

  • Alzheimer's disease (AD) is characterized by pathological protein aggregation in multiple brain regions.
  • Astrocytes, a type of brain cell, play an essential role in maintaining cognitive function even with high levels of harmful tau and amyloid proteins.

Deceptions

100%

Examples:

No current examples available.

Recent Articles

New Insights into Alzheimer's Disease: Reelin, Neurofibrillary Tangles, and Emerging Biomarkers

New Insights into Alzheimer's Disease: Reelin, Neurofibrillary Tangles, and Emerging Biomarkers

Broke On: Monday, 29 July 2024 Alzheimer's disease is a progressive neurodegenerative disorder characterized by memory loss, cognitive decline, and behavioral changes. Recent research reveals its complex nature, focusing on pathological hallmarks - amyloid plaques and tau tangles. New findings suggest that maintaining adequate levels of Reelin protein might protect against amyloid plaque formation. Additionally, understanding cellular responses to neurofibrillary tangles could lead to potential therapeutic strategies. New biomarkers in cerebrospinal fluid offer hope for early detection and prediction.